An increased SGO1 expression was correlated with preoperative prostate-specific antigen, lymph-node metastasis, advanced clinicopathological characteristics, and poor recurrence-free survival time (9). The gene discussed is SGO1; the disease is metastatic malignant neoplasm in the lymph nodes.